Clinical trial

A Randomized Study of Ibuprofen + Oxycodone/Acetaminophen Versus Ibuprofen + Acetaminophen for ED Patients With Insufficient Relief of Acute Musculoskeletal Pain After Treatment With Prescription Strength Ibuprofen

Name
2019-10592
Description
This is an emergency department based randomized study of oxycodone/ acetaminophen versus acetaminophen alone for patients with acute musculoskeletal pain refractory to ibuprofen
Trial arms
Trial start
2019-12-01
Estimated PCD
2022-07-31
Trial end
2022-07-31
Status
Completed
Phase
Early phase I
Treatment
Acetaminophen
Acetaminophen 650mg
Arms:
Acetaminophen, Oxycodone/ acetaminophen
Oxycodone
Oxycodone 10mg
Arms:
Oxycodone/ acetaminophen
Size
393
Primary endpoint
Change in Pain Assessment
2 hours following treatment
Eligibility criteria
Inclusion Criteria: * Acute musculoskeletal pain: Any pain attributable to muscles, bones, joints, tendons, ligaments or supporting structures, as determined by the clinical team, of 10 days duration or less. Prior to the onset of acute pain, patients cannot have experienced pain in the same body region during the prior six months * Pain has to be described as moderate or severe, when the patient is asked if the pain is mild, moderate or severe in intensity Exclusion Criteria: * Use of an non-steroidal anti-inflammatory drug within the previous six hours * Use of acetaminophen within the previous six hours * Use of an opioid within the previous ten days * Chronic pain, defined as any pain on \>50% of days for at least 3 months prior to onset of acute pain * Gout
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 393, 'type': 'ACTUAL'}}
Updated at
2024-02-28

1 organization

2 products

1 indication

Product
Oxycodone